Sign up


Match Document Document Title
8192762 Preparation of soluble and colloidal molecularly imprinted polymers by living polymerization  
The present invention describes a method for synthesis of relatively low molecular weight imprinted polymers using living polymerization, and their application in analytical chemistry,...
8187617 Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments  
Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments.
8187708 Microphasic micro-components and methods for controlling morphology via electrified jetting  
The disclosure provides methods for preparation of multiphasic micro-components, such as core-shell or anisotropic (e.g., Janus) multiphasic particles with well-defined structures using...
8187615 Non-aqueous compositions for oral delivery of insoluble bioactive agents  
The present invention provides a composition of low water solubility drug, dissolved or dispersed in a non crystalline or low crystalline form in an emulsion type composition of internal...
8187629 Non-lamellar compositions of DOPE and P80  
The present invention relates to particulate compositions comprising at least 50% of dioleoyl phosphatidyl ethanolamine (DOPE) and 1 to 50% of Polysorbate 80 (P80). All parts are by weight relative...
8187616 Method for silk fibroin gelation using sonication  
This invention provides for a process of rapidly forming silk fibroin gelation through ultrasonication. Under the appropriate conditions, gelation can be controlled to occur within two hours after...
8187639 Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment  
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and ...
8188308 Crystal of glutathione and process for production thereof  
Disclosed is a crystal of glutathione having an average width of 7 to 40 μm and an average particle diameter of 10 to 60 μm, preferably having an angle of repose of 53 degree or less, more p...
8182824 Ciclesonide-containing sterile aqueous suspension  
The present invention provides a ciclesonide-containing sterile aqueous suspension sterilized by autoclaving, wherein the concentration of ciclesonide after autoclaving is 95% or more compared to...
8182799 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation  
Novel methods and compositions for treating aged and environmentally damaged skin are disclosed which provide improvements in the skin's visual appearance, function and clinical/biophysical...
8182825 Message energy memory ceramics  
The present invention provides a message energy memory ceramics. The message information memory ceramics includes: (1) a plurality of message energy memory ceramics grains composed of a silicon...
8182840 Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition  
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and ...
8183290 Pharmaceutically acceptable propylene glycol solvate of naproxen  
The invention relates to pharmaceutical compositions comprising propylene glycol solvates of APIs. In particular a 2:1 complex of naproxen sodium to propylene glycol is disclosed which is a...
8178112 Ketoprofen compositions and methods of making them  
A wide variety of pharmaceutically and commercially acceptable dosage forms of ketoprofen are prepared by dissolving ketoprofen in pharmaceutically acceptable solvents.
8178518 Pharmaceutical composition  
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening...
8173109 Eyelash cosmetic  
An eyelash cosmetic according to present invention, by blending (a) wax and/or (b) resin, and (c) hollow powder, can impart a voluminous feeling and, at the same time, perform excellent curling...
8173142 Pharmaceutical compositions of drugs and neutralized acidic polymers  
Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
8173708 Method and composition for administering an NMDA receptor antagonist to a subject  
The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
8168208 Silica-calcium phosphate bioactive composite for improved synthetic graft resorbability and tissue regeneration  
A method is disclosed for the generation of bone tissue by the preparation and the application to bone defect sites of a resorbable silica-calcium phosphate bioactive composite (SCPC) that finds...
8168209 Method and composition for administering an NMDA receptor antagonist to a subject  
The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
8168230 Platelet gel comprising platelet-rich plasma, platelet activator and polymer  
A semi-synthetic platelet gel comprising a platelet-rich plasma, at least one platelet activator, and a biocompatible polymer selected from the group comprising carbomers, polyalkylene glycols,...
8163299 Stabilized pharmaceutical product  
Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar.
8163298 Aqueous gel having an alpha-hydroxy acid and suspended particulates  
A personal care composition in the form of an aqueous gel may comprise an alpha-hydroxy acid, wherein the pH of the composition is less than about 4.5. The personal care composition comprises a...
8163272 Sunless tanning substrate  
The present invention provides a sunless tanning substrate having one or more sunless tanning enhancers, which adjust the rate of color development and/or adjust or customize the color developed on...
8163725 Gel compositions and methods of use  
Improved topical gel compositions for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline...
8158153 Nanoparticulate bisphosphonate compositions  
Nanoparticulate bisphosphonate compositions, having an effective average particle size of less than 2000 nm, are described. The compositions are useful in treating bone resorption in a mammal.
8158135 Imine based liquid crystals for the controlled release of bioactive materials  
The present invention relates to a delivery system based on a film of an imine forming liquid crystalline phase, mixed with at least with one biologically active substance, to which a constant or...
8158158 Composite biocidal particles  
A biocidal composition is disclosed comprising composite particles, each of said composite particles containing a shell and a core, said core comprising a metal or a metal-containing compound...
8158615 Anti-viral composition for the topical treatment of Herpes Labialis (cold sores) and method for use thereof  
A composition for the treatment of Herpes Labialis which contains CTC-96 as the active ingredient is disclosed. Methods for using the composition are also disclosed. The composition may be used as...
8158134 Microemulsion preconcentrate, microemulsion and use thereof  
The invention relates to compositions in the form of microemulsion preconcentrates that contain (a) a mixture that consists of a medium-chain triglyceride and an omega-9 fatty acid and/or an...
8158136 Emulsification system for use in cosmetics  
Disclosed are cosmetic compositions containing water, at least one non-polar and/or polar oil, and an emulsification system comprising a polyoxyethylene oxide C12-C24 fatty acid ester; a sucrose...
8153162 Purified amniotic membrane compositions and methods of use  
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and ...
8153142 Skin treatment composition  
A skin treatment composition of the present invention is an external composition for skin comprising an alkylene oxide derivative expressed by Formula (I): R1O-[(AO)m(EO)n]—R2 (I) wherein AO is a...
8153111 Photo-triggered release of active substances from dendrimer-photosensitizer complexes  
Compositions of dendrimer-photosensitizer complexes including therapeutic molecules, and methods for their synthesis and use are disclosed. The therapeutic molecules and the photosensitizers are...
8153105 Sunblock composition with photostabilizer and method of preparation  
A sunblock or sunscreen composition with enhanced photostability and a method for preparing and using the novel photostabilizer are provided. The combination of avobenzene, dimethyl capramide, and...
8147851 Treating eczema and/or psoriasis  
The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and...
8147852 Modified azole compounds as antifungal and antibacterial agents  
The present invention relates to the compounds of formula (I), their preparation and use as antifungal and/or antibacterial agents. where the values for R1, R2, R3, R4, R5 and A are as defined herein.
8148352 Antimicrobial therapy for bacterial infections  
The disclosure provides compounds and methods to treat bacterial pathogenesis, and demonstrates that the S. aureus pigment is a virulence factor and potential novel target for antimicrobial therapy.
8147872 Pharmaceutical compositions of drugs and neutralized acidic polymers  
Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
8147876 Medical agent for preventing or treating diseases resulting from one of inflammation and remodeling, and method for preventing or treating the diseases  
An object of the present invention is to provide a medical agent that has an excellent effect on the diseases resulting from one of inflammation and remodeling and that can prevent or treat them in...
8142800 Oral high potency clinical anti-craving treatment and method of use  
A practical high potency anti-craving oral medication or combined oral/IV drip medication is disclosed which comprises three components: a group of amino-acid substances, a group of vitamin...
8142805 Implantable devices including fixed tissues  
Disclosed are implantable tissues including one or more enzyme inhibitors bound in the tissues, bioprostheses including the tissue, and methods for incorporating enzyme inhibitors in implantable...
8142799 High potency clinical anti-craving treatment and method of use  
A practical high potency anti-craving medication is disclosed which comprises three components: an amino-acid component, a vitamin component, and a mineral component, wherein each component is...
8137706 Prebiotic  
Carbohydrates, in particular mannose containing carbohydrates, are used as a promotor of cell growth. Specifically, polysaccharide hydrolysates are shown to have superior efficacy in promoting the...
8137683 Process for the preparation of dispersions  
The present invention relates to a process of a dispersion of an active substance or composition in a aqueous phase which comprises dispersing in an aqueous phase a solution of such substance or...
8137759 Gold nanostructures and methods of use  
The invention is drawn to novel nanostructures comprising hollow nanospheres and nanotubes for use as chemical sensors, conduits for fluids, and electronic conductors. The nanostructures can be...
8138228 Liquid kelp formulation with or without enhanced shelf life, and method of making  
A liquid kelp formulation includes an enzyme inactivating component and a preservative to extend the shelf life of the formulation in terms of growth hormones. The formulation can also include a...
8137657 Carrier particles for use in dry powder inhalers  
In a method of producing particles suitable for use as carrier particles in dry powder inhalers, particles (1) of a size suitable for use as carrier particles in dry powder inhalers are treated so...
8137692 Solid deodorizer for ostomy pouches  
A solid deodorizer (14) for use on the inside surface (12) of an ostomy pouch (10). The solid deodorizer include a deodorizing mixture (24) and a carrier (16) by which the deodorizer is attached to...
8137660 Application of tannins to reduce odor emissions from animal waste  
Quebracho tannins are effective for the treatment of animal wastes which contain feces or fecal waste-containing material to inhibit odor emissions therefrom. Application of an effective amount of...